Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16297705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA damage-induced apoptosis

  2004cited by this paper
• Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

  2004cited by this paper
• A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin

  2004cited by this paper
• Challenges for Biomarkers in Cancer Detection

  2004cited by this paper
• Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.

  2004cited by this paper
• Identification of an HLA‐DR‐restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM‐MEL‐40/SSX2

  2004cited by this paper
• Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer

  2004cited by this paper
• NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors

  2004cited by this paper
• Immunological and pathobiological roles of fibulin-1 in breast cancer

  2004cited by this paper
• Hsp90: an emerging target for breast cancer therapy

  2004cited by this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cited by this paper
• Judging new markers by their ability to improve predictive accuracy.

  2003cited by this paper
• Disease proteomics

  2003cited by this paper
• Pharmacoproteomics in drug development

  2003cited by this paper
• Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2

  2003cited by this paper
• Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

  2003cited by this paper
• Advantages and limitations of microarray technology in human cancer

  2003cited by this paper
• Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.

  2003cited by this paper
• Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients

  2003cited by this paper
• Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.

  2003cited by this paper
• Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

  2003cited by this paper
• Protein microarrays using liquid phase fractionation of cell lysates

  2003cited by this paper
• Regulation of BRCA1 Transcription by Specific Single-Stranded DNA Binding Factors

  2003cited by this paper
• Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments

  2003cited by this paper
• Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays

  2002cited by this paper
• Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer

  2002cited by this paper
• Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

  2002cited by this paper
• Isolation of Native Human Monoclonal Autoantibodies to Breast Cancer

  2002cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.

  2002cited by this paper
• Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient's Serum

  2002cited by this paper
• ALG-2 interacts with the amino-terminal domain of annexin XI in a Ca(2+)-dependent manner.

  2002cited by this paper
• Proteomics in cancer research

  2002cited by this paper
• Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer.

  2002cited by this paper
• BRCA1 modulates ionizing radiation‐induced nuclear focus formation by the replication protein A p34 subunit

  2002cited by this paper
• Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.

  2002cited by this paper
• Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

  2002cited by this paper
• Identification of novel transcribed sequences on human chromosome 22 by expressed sequence tag mapping.

  2001cited by this paper
• Sequential 5-Aza-2′-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1

  2001cited by this paper
• A Novel Nucleolar Protein, NIFK, Interacts with the Forkhead Associated Domain of Ki-67 Antigen in Mitosis*

  2001cited by this paper
• Contribution of proteomics to tumor immunology

  2001cited by this paper
• Antigen-Specific IgG Antibodies in Stage IV Long-Time Survival Breast Cancer Patients

  2001cited by this paper
• Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

  2001cited by this paper
• Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

  2001cited by this paper
• Early Detection Cancer Research Network

  2000cited by this paper
• p53 Antibodies in the sera of patients with various types of cancer: a review.

  2000cited by this paper
• Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.

  2000cited by this paper
• Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.

  2000cited by this paper
• Antinuclear antibodies as potential markers of lung cancer.

  1999cited by this paper
• Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer

  1999cited by this paper
• Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.

  1999cited by this paper
• Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease

  1999cited by this paper
• Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors.

  1999cited by this paper
• C-erbB-2 in Serum of Patients with Breast Cancer

  1999cited by this paper
• Prognostic significance of apoptosis regulators in breast cancer.

  1999cited by this paper
• Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

  1998cited by this paper
• Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.

  1998cited by this paper
• New Paths in Human Cancer Serology

  1998cited by this paper
• Molecular markers of carcinogenesis.

  1998cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• The role of calcium in apoptosis

  1998cited by this paper
• Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

  1998cited by this paper
• Serological analysis of human tumor antigens: molecular definition and implications.

  1997cited by this paper
• Transcriptional activation functions in BRCA2

  1997cited by this paper
• BRCA1 is a component of the RNA polymerase II holoenzyme.

  1997cited by this paper
• High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.

  1997cited by this paper
• Heat inactivation of Ku autoantigen: possible role in hyperthermic radiosensitization.

  1997cited by this paper
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

  1997cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Autoimmunity to collagen in human lung cancer.

  1996cited by this paper
• Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

  1996cited by this paper
• RPA involvement in the damage-recognition and incision steps of nucleotide excision repair

  1995cited by this paper
• Human neoplasms elicit multiple specific immune responses in the autologous host.

  1995cited by this paper
• Immunity to Oncogenic Proteins

  1995cited by this paper
• Absence of autoantigen Ku in mature human neutrophils and human promyelocytic leukemia line (HL-60) cells and lymphocytes undergoing apoptosis

  1995cited by this paper
• Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

  1994cited by this paper
• The 56K autoantigen is identical to human annexin XI.

  1994cited by this paper
• Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.

  1994cited by this paper
• Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.

  1994cited by this paper
• Serum p53 auto-antibodies: incidence in familial breast cancer.

  1994cited by this paper
• Interaction of the calcium and calmodulin regulated eEF‐2 kinase with heat shock protein 90

  1994cited by this paper
• Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients.

  1993cited by this paper
• Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

  1993cited by this paper
• Antinuclear antibodies heralding the onset of systemic lupus erythematosus.

  1992cited by this paper
• The human homologous pairing protein HPP-1 is specifically stimulated by the cognate single-stranded binding protein hRP-A.

  1991cited by this paper
• Characterization of a cDNA encoding the 70-kDa single-stranded DNA-binding subunit of human replication protein A and the role of the protein in DNA replication.

  1991cited by this paper
• The primary structure of the 32-kDa subunit of human replication protein A.

  1990cited by this paper
• Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome.

  1990cited by this paper
• The primary structure of the human ribosomal protein S6 derived from a cloned cDNA.

  1988cited by this paper
• Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

  1982cited by this paper

• Cutting Edge Diagnostic Methods for Early Diagnoses of Breast Cancer

  2024cites this paper
• Noninvasive Blood-Based Cancer Detection in Veterinary Medicine.

  2024cites this paper
• Autoantibodies in laryngeal cancer: detection and role as a biomarker.

  2024cites this paper
• Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma

  2024cites this paper
• Expression and Function of Mammary Epithelial Cell-Derived Immunoglobulins.

  2024cites this paper
• Prostate cancer autoantibodies - applications in diagnosis, prognosis, monitoring disease progression and immunotherapy.

  2023cites this paper
• Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications

  2022cites this paper
• Agents of cancer immunosurveillance: HSPs and dsDNA.

  2022cites this paper
• Advances in breast cancer screening modalities and status of global screening programs

  2022cites this paper
• Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma

  2021cites this paper
• Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer

  2021cites this paper
• Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression

  2021cites this paper
• A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer

  2021cites this paper
• Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature

  2020cites this paper
• Serum Analysis of Women with Early-Stage Breast Cancer Using a Mini-Array of Tumor-Associated Antigens

  2020cites this paper
• A review of clinical and emerging biomarkers for breast cancers: towards precision medicine for patients

  2020cites this paper
• Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review

  2020cites this paper
• Significant association of serum autoantibodies to TYMS, HAPLN1, and IGFBP5 with early-stage canine malignant mammary tumors.

  2020cites this paper
• Autoantibodies against tumor-associated antigens as one class of serological markers

  2019cites this paper
• Blood-based protein biomarkers in breast cancer.

  2019cites this paper
• Circulating tumor DNA as an early cancer detection tool.

  2019cites this paper
• Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches.

  2019cites this paper
• Autoantibodies as Potential Biomarkers in Breast Cancer

  2018cites this paper
• The future of blood-based biomarkers for the early detection of breast cancer.

  2018cites this paper
• 10 Hyaluronan Associated Inflammation and Microenvironment Remodelling Influences Breast Cancer Progression

  2018cites this paper
• Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.

  2017cites this paper
• Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.

  2017cites this paper
• Array-based Autoantibody Profiling and Epitope Mapping

  2017cites this paper
• Tumour‐Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta‐Analysis

  2016cites this paper
• Paraneoplastic neurological complications of breast cancer

  2016cites this paper
• Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients

  2016cites this paper
• The identification of prostate cancer associated tumour antigens and biomarkers

  2015cites this paper
• Immunosignature: Serum Antibody Profiling for Cancer Diagnostics.

  2015cites this paper
• Alpha 2HS-glycoprotein, a tumor-associated antigen (TAA) detected in Mexican patients with early-stage breast cancer.

  2015cites this paper
• Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer

  2015cites this paper
• Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis

  2015cites this paper
• Dendritic cell-based vaccine research against cancer

  2015cites this paper
• Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review)

  2015cites this paper
• Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

  2015cites this paper
• Comparison patterns of 4 T1 antigens recognized by humoral immune response mediated by IgG and IgM antibodies in female and male mice with breast cancer using 2D-immnunoblots.

  2015cites this paper
• Utilising quantitative immunoproteomics to reveal differential autoantibody biomarker panels in serous ovarian cancer patients

  2015cites this paper
• Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma

  2014cites this paper
• Autoantibodies in breast cancer.

  2014cites this paper
• Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer.

  2014cites this paper
• A Multiparametric Serum Marker Panel as a Complementary Test to Mammography for the Diagnosis of Node-Negative Early-Stage Breast Cancer and DCIS in Young Women

  2014cites this paper
• Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma

  2013cites this paper
• Serologic Autoantibodies as Diagnostic Cancer Biomarkers—A Review

  2013cites this paper
• Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma

  2013cites this paper
• Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

  2013cites this paper
• Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer

  2013cites this paper
• Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis

  2013cites this paper
• Principles and Application of Microarray Technology in Thyroid Cancer Research

  2012cites this paper
• Detection methodology based on target molecule-induced sequence-specific binding to a single-stranded oligonucleotide.

  2012cites this paper
• Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases.

  2012cites this paper
• Tumor-associated autoantibodies as diagnostic and prognostic biomarkers

  2012cites this paper
• Multicenter study identified molecular blood‐born protein signatures for Wilms Tumor

  2012cites this paper
• Alpha 1‐antitrypsin: A novel tumor‐associated antigen identified in patients with early‐stage breast cancer

  2012cites this paper
• Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.

  2012cites this paper
• Serologic laboratory findings in malignancy.

  2011cites this paper
• Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.

  2011cites this paper
• Diagnostic and therapeutic use of membrane proteins in cancer cells.

  2011cites this paper
• Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0‐vaccinated mice

  2011cites this paper
• Leukocytes in mammary development and cancer.

  2011cites this paper
• Hyaluronan Associated Inflammation and Microenvironment Remodelling Influences Breast Cancer Progression

  2011cites this paper
• α‐enolase: a promising therapeutic and diagnostic tumor target

  2011cites this paper
• Immunoglobulin G from Breast Cancer Patients in Stage I Stimulates Muscarinic Acetylcholine Receptors in MCF7 Cells and Induces Proliferation. Participation of Nitric Oxide Synthase-Derived Nitric Oxide

  2010cites this paper
• The roles of ATF3, an adaptive-response gene, in cancer development and metastasis.

  2010cites this paper
• Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.

  2010cites this paper
• Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma

  2010cites this paper
• Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens

  2010cites this paper
• The Tumor-Immune Microenvironment and Response to Radiation Therapy

  2010cites this paper
• Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma

  2010cites this paper
• 肿瘤自身抗体在肺癌早期诊断中的作用

  2010cites this paper
• Autoantibodies against tumor-related antigens: incidence and biologic significance.

  2010cites this paper
• Autoantibody profiles as biomarkers of breast cancer

  2009cites this paper
• Serum autoantibodies as biomarkers for early cancer detection

  2009cites this paper
• Sperm-Associated Antigen 9, a Novel Biomarker for Early Detection of Breast Cancer

  2009influential citation
• Autoantibodies for cancer detection: Still cause for excitement?

  2009cites this paper
• Development and characterization of polyspecific anti‐mitochondrion antibodies for proteomics studies on in toto tissue homogenates

  2009cites this paper
• Calreticulin is a B cell molecular target in some gastrointestinal malignancies

  2009cites this paper
• Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.

  2009cites this paper
• Optical imaging of the peri-tumoral inflammatory response in breast cancer

  2009cites this paper
• A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.

  2009cites this paper
• Immunoproteomics to identify tumor-associated antigens eliciting humoral response.

  2009cites this paper
• Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B.

  2008cites this paper
• Autoantibodies as potential biomarkers for breast cancer

  2008cites this paper
• Quantitative detection of methylated ESR1 and 14-3-3-σ gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy

  2008cites this paper
• The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.

  2008cites this paper
• Immunoregulomics : a serum autoantibody-based platform for transcription factor profiling.

  2008cites this paper
• The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

  2008cites this paper
• Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.

  2008cites this paper
• Cancer mucosa antigens: novel immunotherapeutic targets

  2008cites this paper
• Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).

  2008cites this paper
• Expression of Odontogenic Ameloblast-Associated Protein (ODAM) in Dental and Other Epithelial Neoplasms

  2008cites this paper
• Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

  2008cites this paper
• Breast cancer proteomics: clinical perspectives

  2007cites this paper
• Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.

  2007cites this paper
• Protein microarray platforms for clinical proteomics

  2007cites this paper
• Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients

  2007cites this paper
• Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

  2007cites this paper